Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome

J Minim Invasive Gynecol. 2023 Mar;30(3):192-198. doi: 10.1016/j.jmig.2022.11.013. Epub 2022 Nov 26.

Abstract

Study objective: To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).

Design: This is a retrospective cohort study, conducted through a telephone survey and chart review.

Setting: Minimally invasive gynecologic surgery center in an academic community hospital.

Patients: Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.

Interventions: Telephone survey.

Measurements and main results: We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31-12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the etiology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion.

Conclusion: There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning.

Keywords: Abnormal placentation; Hysteroscopy; Intrauterine adhesions.

MeSH terms

  • Female
  • Gynatresia* / epidemiology
  • Gynatresia* / etiology
  • Gynatresia* / surgery
  • Humans
  • Hysterectomy / adverse effects
  • Incidence
  • Placenta Accreta* / epidemiology
  • Placenta Accreta* / etiology
  • Placenta Accreta* / surgery
  • Placenta Previa* / epidemiology
  • Placenta Previa* / surgery
  • Pregnancy
  • Retrospective Studies